X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (14) 14
oncology (14) 14
aged (11) 11
middle aged (11) 11
female (10) 10
male (10) 10
adult (8) 8
aged, 80 and over (8) 8
cancer (8) 8
carcinoma, renal cell - drug therapy (8) 8
kidney neoplasms - drug therapy (8) 8
survival (8) 8
analysis (6) 6
carcinoma, renal cell (6) 6
care and treatment (6) 6
tumors (6) 6
carcinoma, renal cell - mortality (5) 5
kidney neoplasms - mortality (5) 5
metastasis (5) 5
treatment outcome (5) 5
animals (4) 4
antineoplastic agents (4) 4
carcinoma, renal cell - secondary (4) 4
hematology, oncology and palliative medicine (4) 4
kidney neoplasms - pathology (4) 4
patients (4) 4
proportional hazards models (4) 4
retrospective studies (4) 4
sorafenib (4) 4
survival analysis (4) 4
urology & nephrology (4) 4
abridged index medicus (3) 3
angiogenesis (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - therapeutic use (3) 3
biomarkers (3) 3
c-myc (3) 3
cercopithecus aethiops (3) 3
chemotherapy (3) 3
cos cells (3) 3
everolimus (3) 3
expression (3) 3
indoles - therapeutic use (3) 3
kaplan-meier estimate (3) 3
medical prognosis (3) 3
metastases (3) 3
open-label (3) 3
prognosis (3) 3
protein-serine-threonine kinases - genetics (3) 3
protein-serine-threonine kinases - metabolism (3) 3
proto-oncogene proteins - genetics (3) 3
proto-oncogene proteins - metabolism (3) 3
proto-oncogene proteins c-pim-1 (3) 3
pyrroles - therapeutic use (3) 3
sunitinib (3) 3
survival rate (3) 3
targeted therapy (3) 3
transfection (3) 3
transgenic mice (3) 3
urology (3) 3
vascular endothelial growth factor (3) 3
young adult (3) 3
angiogenesis inhibitors (2) 2
angiogenesis inhibitors - therapeutic use (2) 2
antimitotic agents (2) 2
apoptosis (2) 2
bad (2) 2
bcl- 2 (2) 2
carrier proteins - metabolism (2) 2
clear cell-type renal cell carcinoma (2) 2
clinical trials (2) 2
combination (2) 2
development and progression (2) 2
disease-free survival (2) 2
dose-response relationship, drug (2) 2
efficacy (2) 2
endothelial growth-factor (2) 2
everolimus - adverse effects (2) 2
follow-up studies (2) 2
gene expression regulation, neoplastic (2) 2
growth (2) 2
health aspects (2) 2
hemic and lymphatic diseases (2) 2
hypertension (2) 2
hypertension - chemically induced (2) 2
indoles - administration & dosage (2) 2
indoles - adverse effects (2) 2
inhibits apoptosis (2) 2
journal article (2) 2
kidney cancer (2) 2
kidney neoplasms (2) 2
kinase (2) 2
management (2) 2
mice (2) 2
multicenter (2) 2
multivariate analysis (2) 2
myeloid cells (2) 2
n-myc (2) 2
neoplasm staging (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 917 - 927
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1814 - 1823
Journal Article
BJU International, ISSN 1464-4096, 01/2016, Volume 117, Issue 1, pp. 110 - 117
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 03/2019, Volume 145, Issue 3, pp. 765 - 774
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 6, pp. 962 - 971
Journal Article
by Fuchs, Charles S and Shitara, Kohei and Di Bartolomeo, Maria and Lonardi, Sara and Al-Batran, Salah-Eddin and Van Cutsem, Eric and Ilson, David H and Alsina, Maria and Chau, Ian and Lacy, Jill and Ducreux, Michel and Mendez, Guillermo Ariel and Alavez, Alejandro Molina and Takahari, Daisuke and Mansoor, Wasat and Enzinger, Peter C and Gorbounova, Vera and Wainberg, Zev A and Hegewisch-Becker, Susanna and Ferry, David and Lin, Ji and Carlesi, Roberto and Das, Mayukh and Shah, Manish A and Luft, Alexander V and Karaseva, Nina A and Kowalyszyn, Rubén Dario and Hernandez, Carlos Alberto and Csoszi, Tibor and De Vita, Ferdinando and Pfeiffer, Per and Sugimoto, Naotoshi and Kocsis, Judit and Csilla, Andràs and Bodoky, Gyorgy and Garnica Jaliffe, Georgina and Protsenko, Svetlana and Madi, Ayman and Wojcik, Elzbieta and Brenner, Baruch and Folprecht, Gunnar and Sarosiek, Tomasz and Peltola, Katriina Johanna and Bono, Peter and Ayala, Hubert and Aprile, Giuseppe and Gerardo, Cardellino Giovanni and Huitzil Melendez, Fidel David and Falcone, Alfredo and Di Costanzo, Francesco and Tehfe, Moustapha and Mineur, Laurent and García Alfonso, Pilar and Obermannova, Radka and Senellart, Hélène and Petty, Russell and Samuel, Leslie and Acs, Peter Istvan and Hussein, Maen Abdelkarim and Nechaeva, Marina N and Erdkamp, F.L.G and Won, Elizabeth and Bendell, Johanna Chock and Gallego Plazas, Javier and Lorenzen, Sylvie and Melichar, Bohuslav and Escudero, Miguel Angel and Pezet, Denis and Phelip, Jean-Marc and Kaen, Diego Lucas and Reeves, James A. Jr and Longo Muñoz, Federico and Madhusudan, Srinivasan and Barone, Carlo and Fein, Luis Enrique and Gomez Villanueva, Angel and Hebbar, Mohamed and Prausova, Jana and Visa Turmo, Laura and Vidal Barrull, Joana and Yilmaz, Mette Karen Nytoft and Beny, Alex and Van Laarhoven, H.M.W and DiCarlo, Brian Anthony and Esaki, Taito and Fujitani, Kazumasa and Geboes, Karen and Geva, Ravit and Kadowaki, Shigenori and Leong, Stephen and Machida, Nozomu and Raj, Moses Sundar and Ramirez Godinez, Francisco Javier and Ruzsa, Agnes and Ford, Hugo and Lawler, William E and Maisey, Nicolas Robert and Petera, Jiri and Shacham-Shmueli, Einat and Sinapi, Isabelle and ... and RAINFALL Study Grp and RAINFALL Study Group
The Lancet Oncology, ISSN 1470-2045, 03/2019, Volume 20, Issue 3, pp. 420 - 435
VEGF and VEGF receptor 2 (VEGFR-2)-mediated signalling and angiogenesis can contribute to the pathogenesis and progression of gastric cancer. We aimed to... 
EXPOSURE-RESPONSE | MULTICENTER | GASTROESOPHAGEAL JUNCTION | ANGIOGENESIS | ONCOLOGY | BEVACIZUMAB | COMBINATION | CANCER | EXPRESSION | CHEMOTHERAPY | ENDOTHELIAL GROWTH-FACTOR | Adenocarcinoma | Antimitotic agents | Care and treatment | Analysis | Clinical trials | Product development | Metastasis | Antineoplastic agents | Rain and rainfall
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2018, Volume 36, Issue 28, pp. 2836 - 2844
PurposeMetastatic esophagogastric cancer treatments after failure of second-line chemotherapy are limited. Nivolumab demonstrated superior overall survival... 
GASTROESOPHAGEAL | OPEN-LABEL | SOLID TUMORS | ONCOLOGY | BLOCKADE | PD-1 | ORIGINAL REPORTS
Journal Article